Fenwal, a Fresenius Kabi company, announced today it has received 60601-1 3rd edition certification for the Aurora™ plasmapheresis system designed for collection of plasma. 60601-1 3rd edition is the ...

LAKE ZURICH, Ill., Aug. 19 Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug ...

LAKE ZURICH, Ill., Dec. 16, 2010 /PRNewswire/ -- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today the U.S.

LAKE ZURICH, Ill.--(BUSINESS WIRE)-- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has received CE ...

Fenwal, a global medical technology company focused on improving blood collection, to ensure the availability, safety and effectiveness of blood components, received FDA clearance for wireless data ...

The U.S. Food and Drug Administration has cleared for marketing a new source plasma collection system developed by Fenwal, Inc., the company announced today. Called the Aurora TM plasmapheresis system ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, announced ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fenwal Inc., a Fresenius Kabi company, announced today it has received clearance from the U.S. Food and Drug Administration for a functionally closed disposable set ...

HemaTerra Technologies, provider of end-to-end operational software products to blood centers, announced that it will work with Fenwal Inc. to develop a companion product to HemaConnect, the ...

Illinois-based Fenwal and Golden Meditech Holdings of Hong Kong have inked an agreement to form a Chinese joint venture that will sell products and technologies for blood collection, storage and ...